Phase IB study of cabozantinib in patients with relapsed and/or refractory multiple myeloma. Article uri icon

Overview

publication date

  • March 28, 2016

Research

keywords

  • Anilides
  • Multiple Myeloma
  • Neoplasm Recurrence, Local
  • Protein Kinase Inhibitors
  • Pyridines
  • Receptor Protein-Tyrosine Kinases

Identity

PubMed Central ID

  • PMC5003505

Scopus Document Identifier

  • 84969213631

Digital Object Identifier (DOI)

  • 10.1182/blood-2016-01-694786

PubMed ID

  • 27020089

Additional Document Info

volume

  • 127

issue

  • 19